Aligos Therapeutics (ALGS) Tax Provisions (2020 - 2026)
Aligos Therapeutics (ALGS) reported Tax Provisions of $317000.0 for Q1 2026, up 637.21% on a YoY basis from $43000.0 in Q1 2025, and up 956.67% quarter-over-quarter from $30000.0 in Q4 2025.
Aligos Therapeutics (ALGS) Tax Provisions (2020 - 2026) Analysis & Trends
Aligos Therapeutics has reported Tax Provisions for 7 years, with the latest figure at $317000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 637.21% year-over-year to $317000.0; the trailing twelve-month figure through Mar 2026 stood at $588000.0 (up 68.0% YoY), and the FY2025 full-year result was $314000.0, down 5.14% from the prior year.
- Tax Provisions for Q1 2026 stood at $317000.0, up from $30000.0 in the prior quarter.
- The five-year high for Tax Provisions was $757000.0 in Q2 2023, with the low at -$43000.0 in Q3 2022.
- Historically, Tax Provisions has averaged $109588.2 across 5 years, with a median of $47000.0 in 2022.
- The largest YoY upside for Tax Provisions was 1510.64% in 2023 against a maximum downside of 161.22% in 2023.
- Aligos Therapeutics' Tax Provisions stood at $49000.0 in 2022, then plunged by 161.22% to -$30000.0 in 2023, then surged by 190.0% to $27000.0 in 2024, then rose by 11.11% to $30000.0 in 2025, then surged by 956.67% to $317000.0 in 2026.
- The last three Tax Provisions figures came in at $317000.0 (Q1 2026), $30000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Aligos Therapeutics | 51.70 Mn | -28.13 Mn | - | 317,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 317,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 189,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 757,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | -43,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Sep 30, 2021 | 126,000.00 |
| Jun 30, 2021 | 28,000.00 |